Clinical efficacy of ambroxol combined with budesonide aerosol inhalation in treating neonatal pneumonia
10.3969/j.issn.1005-1678.2017.03.073
- VernacularTitle:氨溴索联合布地奈德雾化吸入治疗新生儿肺炎的临床效果
- Author:
Min LU
;
Jianfei TAN
- Keywords:
neonatal pneumonia;
ambroxol;
budesonide;
hemodynamics
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(3):237-239
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effect of aerosol inhalation of ambroxol combined with budesonide on neonatal pneumonia .Methods 66 infants with pneumonia treated were enrolled in this study.The patients were divided into observation group ( n =33 ) and control group ( n =33 ) according to the random number method.The treatment group were treated with ambroxol combined with budesonide and the control group were treated with budesonide.The two groups of infant lung function, clinical outcomes and blood flow were compared.Results The total effective rate (93.94%) in the observation group was significantly higher than that in the control group (45.45%), there was significant difference between the two groups (P<0.05).After treatment, FEV1 and PEF in the two groups were significantly higher than those before treatment, the observation group [(95.21 ± 7.69)%, (93.21 ±7.89)%] were significantly higher than those of the control group[(87.03 ±7.23)%, (84.55 ±7.45)%], the differences between the two groups were statistically significant (P<0.05).The OI of the two groups was significantly higher than that of the control group and the OI of the observation group was significantly higher than that of the control group.PaCO2 of the two groups decreased significantly and the PaCO2 of the observation group was significantly lower than that of the control group, the difference was statistically significant ( P<0.05 ).Conclusion The combination of ambroxol and budesonide is effective in the treatment of neonatal pneumonia.It can effectively improve the infant pulmonary function, shorten the treatment time and improve the hemodynamics of infants .
